Coronavirus cases surge in United Kingdom as Delta variant worries officials

News and Info from Deeside Flintshire North Wales

The Kremlin blamed a surge in Covid-19 cases on reluctance to have vaccinations and "nihilism" after record new infections in Moscow, mostly with the new Delta variant, fanned fears of a third wave.

Some 33,630 cases of the mutation were recorded in the last week and PHE said "the most recent data show 99% of sequenced and genotyped cases across the country are the Delta variant".

Also speaking on Thursday the HSE's chief clinical officer Dr Colm Henry said 189 cases of the Delta variant have been identified in the Republic of Ireland.

Earlier this week, Prime Minister Boris Johnson announced a delay in plans to lift most remaining anti-infection restrictions in England by about one month.

Experts have warned that coronavirus may continue to evolve for years to come, and eventually it is likely current vaccines will fail to protect against transmission, infection, or even against disease caused by newer variants.

Of these, 527 were unvaccinated and only 84 of the 806 had received both doses - although it is unclear how long it had been since their second dose, as it takes a couple of weeks to build up protection.

"PHE's weekly COVID-19 variant cases data show that numbers of the Delta variant in the United Kingdom have risen by 33,630 since last week to a total of 75,953", PHE reports. It is encouraging to see that hospitalisations and deaths are not rising at the same rate but we will continue to monitor it closely.

"The vaccination programme and the care that we are all taking to follow the guidance are continuing to save lives".

"While we know that people can catch viruses a couple of times, this data now suggests that the rate of COVID-19 reinfection is low", said Dr Susan Hopkins, Strategic Director for COVID-19 at PHE.

Public Health England now publishes the number of deaths among people who have tested positive for Delta within the past 28 days.

"Just because it's another mRNA vaccine, we can not presume all mRNA vaccines are the same, because each one has a slightly different technology", Swaminathan said, adding the surprise failure underscored the value of robust clinical trials to test new products.

Related:

Comments


Other news